BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Deurholt T, van Til NP, Chhatta AA, ten Bloemendaal L, Schwartlander R, Payne C, Plevris JN, Sauer IM, Chamuleau RA, Elferink RP, Seppen J, Hoekstra R. Novel immortalized human fetal liver cell line, cBAL111, has the potential to differentiate into functional hepatocytes. BMC Biotechnol 2009;9:89. [PMID: 19845959 DOI: 10.1186/1472-6750-9-89] [Cited by in Crossref: 34] [Cited by in F6Publishing: 32] [Article Influence: 2.8] [Reference Citation Analysis]
Number Citing Articles
1 Hoekstra R, Nibourg GA, van der Hoeven TV, Ackermans MT, Hakvoort TB, van Gulik TM, Lamers WH, Elferink RP, Chamuleau RA. The HepaRG cell line is suitable for bioartificial liver application. Int J Biochem Cell Biol. 2011;43:1483-1489. [PMID: 21726661 DOI: 10.1016/j.biocel.2011.06.011] [Cited by in Crossref: 64] [Cited by in F6Publishing: 65] [Article Influence: 6.4] [Reference Citation Analysis]
2 Nibourg GAA, Hoekstra R, van der Hoeven TV, Ackermans MT, Hakvoort TBM, van Gulik TM, Chamuleau RAFM. Effects of acute-liver-failure-plasma exposure on hepatic functionality of HepaRG-AMC-Bioartificial Liver. Liver Int 2013;33:516-24. [DOI: 10.1111/liv.12090] [Cited by in Crossref: 13] [Cited by in F6Publishing: 11] [Article Influence: 1.6] [Reference Citation Analysis]
3 Gleich A, Kaiser B, Honscha W, Fuhrmann H, Schoeniger A. Evaluation of the hepatocyte-derived cell line BFH12 as an in vitro model for bovine biotransformation. Cytotechnology 2019;71:231-44. [PMID: 30617848 DOI: 10.1007/s10616-018-0279-4] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
4 Pongjantarasatian S, Kadegasem P, Sasanakul W, Sa-Ngiamsuntorn K, Borwornpinyo S, Sirachainan N, Chuansumrit A, Tanratana P, Hongeng S. Coagulant activity of recombinant human factor VII produced by lentiviral human F7 gene transfer in immortalized hepatocyte-like cell line. PLoS One 2019;14:e0220825. [PMID: 31381603 DOI: 10.1371/journal.pone.0220825] [Reference Citation Analysis]
5 Adam AAA, van Wenum M, van der Mark VA, Jongejan A, Moerland PD, Houtkooper RH, Wanders RJA, Oude Elferink RP, Chamuleau RAFM, Hoekstra R. AMC-Bio-Artificial Liver culturing enhances mitochondrial biogenesis in human liver cell lines: The role of oxygen, medium perfusion and 3D configuration. Mitochondrion 2018;39:30-42. [PMID: 28844938 DOI: 10.1016/j.mito.2017.08.011] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.8] [Reference Citation Analysis]
6 Ramboer E, De Craene B, De Kock J, Berx G, Rogiers V, Vanhaecke T, Vinken M. Development and characterization of a new human hepatic cell line. EXCLI J 2015;14:875-89. [PMID: 26869867 DOI: 10.17179/excli2015-424] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
7 Nibourg GA, Hoekstra R, van der Hoeven TV, Ackermans MT, Hakvoort TB, van Gulik TM, Chamuleau RA. Increased hepatic functionality of the human hepatoma cell line HepaRG cultured in the AMC bioreactor. Int J Biochem Cell Biol 2013;45:1860-8. [PMID: 23770120 DOI: 10.1016/j.biocel.2013.05.038] [Cited by in Crossref: 23] [Cited by in F6Publishing: 20] [Article Influence: 2.9] [Reference Citation Analysis]
8 Pan X, Li L. Advances in cell sources of hepatocytes for bioartificial liver. Hepatobiliary & Pancreatic Diseases International 2012;11:594-605. [DOI: 10.1016/s1499-3872(12)60230-6] [Cited by in Crossref: 16] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
9 Nibourg GA, Chamuleau RA, van der Hoeven TV, Maas MA, Ruiter AF, Lamers WH, Oude Elferink RP, van Gulik TM, Hoekstra R. Liver progenitor cell line HepaRG differentiated in a bioartificial liver effectively supplies liver support to rats with acute liver failure. PLoS One 2012;7:e38778. [PMID: 22719943 DOI: 10.1371/journal.pone.0038778] [Cited by in Crossref: 43] [Cited by in F6Publishing: 35] [Article Influence: 4.8] [Reference Citation Analysis]
10 Choi JM, Oh SJ, Lee SY, Im JH, Oh JM, Ryu CS, Kwak HC, Lee JY, Kang KW, Kim SK. HepG2 cells as an in vitro model for evaluation of cytochrome P450 induction by xenobiotics. Arch Pharm Res 2015;38:691-704. [PMID: 25336106 DOI: 10.1007/s12272-014-0502-6] [Cited by in Crossref: 46] [Cited by in F6Publishing: 42] [Article Influence: 6.6] [Reference Citation Analysis]
11 Nibourg GAA, Huisman MT, van der Hoeven TV, van Gulik TM, Chamuleau RAFM, Hoekstra R. Stable overexpression of Pregnane X receptor in HepG2 cells increases its potential for bioartificial liver application: PXR Overexpression in HEPG2 for a Bioartificial Liver. Liver Transpl 2010;16:1075-85. [DOI: 10.1002/lt.22110] [Cited by in Crossref: 29] [Cited by in F6Publishing: 25] [Article Influence: 2.6] [Reference Citation Analysis]
12 Ramboer E, Vanhaecke T, Rogiers V, Vinken M. Immortalized Human Hepatic Cell Lines for In Vitro Testing and Research Purposes. Methods Mol Biol 2015;1250:53-76. [PMID: 26272134 DOI: 10.1007/978-1-4939-2074-7_4] [Cited by in Crossref: 23] [Cited by in F6Publishing: 22] [Article Influence: 4.6] [Reference Citation Analysis]
13 Chaudhari P, Tian L, Deshmukh A, Jang YY. Expression kinetics of hepatic progenitor markers in cellular models of human liver development recapitulating hepatocyte and biliary cell fate commitment. Exp Biol Med (Maywood). 2016;241:1653-1662. [PMID: 27390263 DOI: 10.1177/1535370216657901] [Cited by in Crossref: 17] [Cited by in F6Publishing: 19] [Article Influence: 3.4] [Reference Citation Analysis]
14 Burgess HM, Pourchet A, Hajdu CH, Chiriboga L, Frey AB, Mohr I. Targeting Poxvirus Decapping Enzymes and mRNA Decay to Generate an Effective Oncolytic Virus. Mol Ther Oncolytics 2018;8:71-81. [PMID: 29888320 DOI: 10.1016/j.omto.2018.01.001] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
15 Collins DP, Hapke JH, Aravalli RN, Steer CJ. Development of immortalized human hepatocyte-like hybrid cells by fusion of multi-lineage progenitor cells with primary hepatocytes. PLoS One 2020;15:e0234002. [PMID: 32497071 DOI: 10.1371/journal.pone.0234002] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
16 Wang LR, Lin YQ, Wang JT, Pan LL, Huang KT, Wan L, Zhu GQ, Liu WY, Braddock M, Zheng MH. Recent advances in re-engineered liver: de-cellularization and re-cellularization techniques. Cytotherapy 2015;17:1015-24. [PMID: 25981396 DOI: 10.1016/j.jcyt.2015.04.003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
17 Gleich A, Kaiser B, Schumann J, Fuhrmann H. Establishment and characterisation of a novel bovine SV40 large T-antigen-transduced foetal hepatocyte-derived cell line. In Vitro Cell Dev Biol -Animal 2016;52:662-72. [DOI: 10.1007/s11626-016-0018-0] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
18 Zhao LF, Pan XP, Li LJ. Key challenges to the development of extracorporeal bioartificial liver support systems. Hepatobiliary Pancreat Dis Int 2012;11:243-9. [PMID: 22672816 DOI: 10.1016/s1499-3872(12)60155-6] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
19 Wang S, Nagrath D. Liver Tissue Engineering. In: Burdick JA, Mauck RL, editors. Biomaterials for Tissue Engineering Applications. Vienna: Springer; 2011. pp. 389-419. [DOI: 10.1007/978-3-7091-0385-2_14] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
20 Sato M, Saitoh I, Inada E, Nakamura S, Watanabe S. Potential for Isolation of Immortalized Hepatocyte Cell Lines by Liver-Directed In Vivo Gene Delivery of Transposons in Mice. Stem Cells Int 2019;2019:5129526. [PMID: 31281376 DOI: 10.1155/2019/5129526] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
21 Legallais C, Kim D, Mihaila SM, Mihajlovic M, Figliuzzi M, Bonandrini B, Salerno S, Yousef Yengej FA, Rookmaaker MB, Sanchez Romero N, Sainz-Arnal P, Pereira U, Pasqua M, Gerritsen KGF, Verhaar MC, Remuzzi A, Baptista PM, De Bartolo L, Masereeuw R, Stamatialis D. Bioengineering Organs for Blood Detoxification. Adv Healthc Mater 2018;7:e1800430. [PMID: 30230709 DOI: 10.1002/adhm.201800430] [Cited by in Crossref: 20] [Cited by in F6Publishing: 15] [Article Influence: 6.7] [Reference Citation Analysis]
22 Mišík M, Nersesyan A, Ropek N, Huber WW, Haslinger E, Knasmueller S. Use of human derived liver cells for the detection of genotoxins in comet assays. Mutat Res 2019;845:402995. [PMID: 31561885 DOI: 10.1016/j.mrgentox.2018.12.003] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
23 Lee SY, Kim HJ, Choi D. Cell sources, liver support systems and liver tissue engineering: alternatives to liver transplantation. Int J Stem Cells. 2015;8:36-47. [PMID: 26019753 DOI: 10.15283/ijsc.2015.8.1.36] [Cited by in Crossref: 47] [Cited by in F6Publishing: 45] [Article Influence: 7.8] [Reference Citation Analysis]
24 Kleine M, Riemer M, Krech T, DeTemple D, Jäger MD, Lehner F, Manns MP, Klempnauer J, Borlak J, Bektas H, Vondran FW. Explanted diseased livers - a possible source of metabolic competent primary human hepatocytes. PLoS One 2014;9:e101386. [PMID: 24999631 DOI: 10.1371/journal.pone.0101386] [Cited by in Crossref: 40] [Cited by in F6Publishing: 41] [Article Influence: 5.7] [Reference Citation Analysis]
25 Norton P, Comunale MA, Herrera H, Wang M, Houser J, Wimmerova M, Romano PR, Mehta A. Development and application of a novel recombinant Aleuria aurantia lectin with enhanced core fucose binding for identification of glycoprotein biomarkers of hepatocellular carcinoma. Proteomics 2016;16:3126-36. [PMID: 27650323 DOI: 10.1002/pmic.201600064] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
26 Andria B, Bracco A, Cirino G, Chamuleau RA. Liver Cell Culture Devices. Cell Med 2010;1:55-70. [PMID: 26998397 DOI: 10.3727/215517910X519274] [Cited by in Crossref: 7] [Cited by in F6Publishing: 2] [Article Influence: 0.6] [Reference Citation Analysis]
27 El Filali E, Duijst S, Hiralall JK, Legrand N, van Gulik T, Hoekstra R, Seppen J. Human fetal liver cells for regulated ex vivo erythropoietin gene therapy. Mol Ther Methods Clin Dev 2014;1:14003. [PMID: 26015950 DOI: 10.1038/mtm.2014.3] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
28 Khazali AS, Clark AM, Wells A. A Pathway to Personalizing Therapy for Metastases Using Liver-on-a-Chip Platforms. Stem Cell Rev Rep 2017;13:364-80. [PMID: 28425064 DOI: 10.1007/s12015-017-9735-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 4.0] [Reference Citation Analysis]
29 Collins DP, Hapke JH, Aravalli RN, Steer CJ. In vitro Differentiation of Human TERT-Transfected Multi-Lineage Progenitor Cells (MLPC) into Immortalized Hepatocyte-Like Cells. Hepat Med 2020;12:79-92. [PMID: 32607015 DOI: 10.2147/HMER.S245916] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
30 Nibourg GA, Chamuleau RA, van Gulik TM, Hoekstra R. Proliferative human cell sources applied as biocomponent in bioartificial livers: a review. Expert Opinion on Biological Therapy 2012;12:905-21. [DOI: 10.1517/14712598.2012.685714] [Cited by in Crossref: 29] [Cited by in F6Publishing: 30] [Article Influence: 3.2] [Reference Citation Analysis]
31 Ramboer E, De Craene B, De Kock J, Vanhaecke T, Berx G, Rogiers V, Vinken M. Strategies for immortalization of primary hepatocytes.J Hepatol. 2014;61:925-943. [PMID: 24911463 DOI: 10.1016/j.jhep.2014.05.046] [Cited by in Crossref: 55] [Cited by in F6Publishing: 53] [Article Influence: 7.9] [Reference Citation Analysis]
32 Palakkan AA, Hay DC, Pr AK, Tv K, Ross JA. Liver tissue engineering and cell sources: issues and challenges. Liver Int 2013;33:666-76. [DOI: 10.1111/liv.12134] [Cited by in Crossref: 80] [Cited by in F6Publishing: 69] [Article Influence: 10.0] [Reference Citation Analysis]